抗软骨寡聚基质蛋白抗体在小鼠中具有致病性并可能与类风湿关节炎临床相关
本研究通过被动转移实验探究单克隆抗软骨寡聚基质蛋白(COMP)抗体15A11在小鼠中的致病性,用晶体结构解析其与COMP表位P6的结合,并在瑞典大型类风湿关节炎(RA)队列中检测血清IgG抗COMP P6肽及其瓜氨酸化变体的临床相关性;结果显示15A11可在初始小鼠中诱导关节炎,抗P6抗体水平在RA患者中显著高于健康对照并与更高疾病活动度评分相关。
要点
- 小鼠单克隆抗COMP抗体15A11可在初始小鼠中诱导关节炎。
- 15A11-P6复合物晶体结构解释了抗体与COMP结合的结构基础,且该结合可受钙离子调控。
- RA患者血清抗COMP P6肽及其瓜氨酸化变体IgG水平显著高于健康对照,并与更高疾病活动度评分相关。
核心结论
- 研究为致病性抗COMP抗体与软骨结合提供了结构基础;所识别的表位可被瓜氨酸化,针对该表位的抗体水平在RA患者中升高并与更高疾病活动度相关,提示抗COMP抗体在部分RA患者中具有致病作用。
研究设计与样本
- 研究采用小鼠被动转移实验探究单克隆抗COMP抗体的致病性,并用免疫组化染色探索抗COMP抗体与软骨的相互作用。
- 通过X射线晶体学解析单克隆抗体15A11与其特异性COMP表位P6复合物的结构,并用酶联免疫吸附试验和表面等离子共振技术研究钙离子与15A11结合的调控。
- 在瑞典大型RA患者队列中评估血清抗COMP P6表位及其瓜氨酸化变体特异性IgG的临床相关性与价值。
主要发现
- 小鼠单克隆抗COMP抗体15A11可在初始小鼠中诱导关节炎。
- 15A11-P6复合物的晶体结构解释了抗体如何与COMP结合,且该结合可受钙离子调控。
- RA患者血清中抗COMP P6肽及其瓜氨酸化变体特异性IgG水平显著高于健康对照,并与更高疾病活动度评分相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cartilage oligomeric matrix protein (COMP) is an autoantigen in rheumatoid arthritis (RA) and experimental models of arthritis. This study was undertaken to investigate the structure, function, and relevance of anti-COMP antibodies. METHODS: We investigated the pathogenicity of monoclonal anti-COMP antibodies in mice using passive transfer experiments, and we explored the interaction of anti-COMP antibodies with cartilage using immunohistochemical staining. The interaction of the monoclonal antibody 15A11 in complex with its specific COMP epitope P6 was determined by x-ray crystallography. An enzyme-linked immunosorbent assay and a surface plasma resonance technique were used to study the modulation of calcium ion binding to 15A11. The clinical relevance and value of serum IgG specific to the COMP P6 epitope and its citrullinated variants were evaluated in a large Swedish cohort of RA patients. RESULTS: The murine monoclonal anti-COMP antibody 15A11 induced arthritis in naive mice. The crystal structure of the 15A11-P6 complex explained how the antibody could bind to COMP, which can be modulated by calcium ions. Moreover, serum IgG specific to the COMP P6 peptide and its citrullinated variants was detectable at significantly higher levels in RA patients compared to healthy controls and correlated with a higher disease activity score. CONCLUSION: Our findings provide the structural basis for binding a pathogenic anti-COMP antibody to cartilage. The recognized epitope can be citrullinated, and levels of antibodies to this epitope are elevated in RA patients and correlate with higher disease activity, implicating a pathogenic role of anti-COMP antibodies in a subset of RA patients.
引用
- Ge C, Tong D, Lönnblom E, et al. Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis. Arthritis Rheumatol. 2022. PMID: 35080151. doi:10.1002/art.42072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。